Natera Cost of Goods Sold 2014-2024 | NTRA

Natera annual/quarterly cost of goods sold history and growth rate from 2014 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Natera cost of goods sold for the quarter ending June 30, 2024 was $0.170B, a 18.88% increase year-over-year.
  • Natera cost of goods sold for the twelve months ending June 30, 2024 was $0.628B, a 17.34% increase year-over-year.
  • Natera annual cost of goods sold for 2023 was $0.59B, a 29.28% increase from 2022.
  • Natera annual cost of goods sold for 2022 was $0.456B, a 43.29% increase from 2021.
  • Natera annual cost of goods sold for 2021 was $0.318B, a 56.38% increase from 2020.
Natera Annual Cost of Goods Sold
(Millions of US $)
2023 $590
2022 $456
2021 $318
2020 $204
2019 $175
2018 $166
2017 $140
2016 $136
2015 $113
2014 $78
2013 $37
Natera Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $170
2024-03-31 $159
2023-12-31 $151
2023-09-30 $147
2023-06-30 $143
2023-03-31 $148
2022-12-31 $127
2022-09-30 $117
2022-06-30 $109
2022-03-31 $103
2021-12-31 $94
2021-09-30 $81
2021-06-30 $76
2021-03-31 $67
2020-12-31 $60
2020-09-30 $52
2020-06-30 $47
2020-03-31 $45
2019-12-31 $44
2019-09-30 $44
2019-06-30 $44
2019-03-31 $43
2018-12-31 $43
2018-09-30 $42
2018-06-30 $41
2018-03-31 $41
2017-12-31 $37
2017-09-30 $35
2017-06-30 $35
2017-03-31 $34
2016-12-31 $38
2016-09-30 $34
2016-06-30 $31
2016-03-31 $32
2015-12-31 $32
2015-09-30 $30
2015-06-30 $26
2015-03-31 $25
2014-12-31
2014-09-30 $21
2014-06-30 $19
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $16.712B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.766B 11.88
Cencora (COR) United States $49.023B 18.08
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $17.511B 15.60
Viatris (VTRS) United States $15.433B 4.75
Avantor (AVTR) United States $14.831B 22.24
Revvity (RVTY) United States $14.647B 25.44
BioMerieux (BMXMF) France $12.894B 0.00
CochLear (CHEOY) Australia $12.739B 0.00
Solventum (SOLV) United States $12.214B 0.00
Medpace Holdings (MEDP) United States $11.215B 31.59
Charles River Laboratories (CRL) United States $11.042B 21.34
Doximity (DOCS) United States $10.778B 63.79
HealthEquity (HQY) United States $8.750B 47.49
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Bausch + Lomb (BLCO) Canada $6.881B 32.03
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.402B 23.55
Organon (OGN) United States $4.012B 4.05
Surgery Partners (SGRY) United States $3.759B 42.85
BrightSpring Health Services (BTSG) United States $3.402B 72.37
PACS (PACS) United States $3.129B 0.00
Concentras Parent (CON) United States $2.579B 0.00
Alignment Healthcare (ALHC) United States $2.523B 0.00
Ardent Health Partners (ARDT) United States $2.446B 0.00
Premier (PINC) United States $2.301B 11.48
GeneDx Holdings (WGS) United States $2.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.783B 47.00
Teladoc Health (TDOC) United States $1.670B 0.00
Progyny (PGNY) United States $1.551B 29.62
Pediatrix Medical (MD) United States $1.331B 13.02
CareDx (CDNA) United States $1.251B 0.00
Establishment Labs Holdings (ESTA) $1.184B 0.00
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Embecta (EMBC) United States $0.898B 5.99
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
InnovAge Holding (INNV) United States $0.778B 0.00
Agilon Health (AGL) United States $0.770B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.442B 0.00
DocGo (DCGO) United States $0.426B 16.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.346B 0.00
LifeMD (LFMD) United States $0.310B 0.00
ModivCare (MODV) United States $0.244B 13.24
Sera Prognostics (SERA) United States $0.242B 0.00
Beauty Health (SKIN) United States $0.211B 0.00
Nutex Health (NUTX) United States $0.204B 0.00
Biodesix (BDSX) United States $0.204B 0.00
MultiPlan (MPLN) United States $0.141B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.073B 17.77
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.051B 0.00
NeueHealth (NEUE) United States $0.042B 1.12
Co-Diagnostics (CODX) United States $0.037B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00